Medical Imaging Screening for Posterior-circulation Ischemic Stroke
1 other identifier
observational
1,000
1 country
4
Brief Summary
Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment. We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization. We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
October 16, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
October 23, 2023
October 1, 2023
10.6 years
October 16, 2023
October 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified ranking scale (mRS) at 90 days
A 0-6 scale running from perfect health without symptoms to death.
90 days
Secondary Outcomes (1)
Mortality within 90 days
90 days
Other Outcomes (3)
National Institutes of Health Stroke Scale (NIHSS) scores at 90 days
90 days
Occurrence of periprocedural complications
90 days
pc-ASPECT (posterior circulation Alberta Stroke Program Early CT score)
0 days
Study Arms (2)
Endovascular therapy
Timely thrombectomy for acute ischemic stroke patients with large vessel occlusion by either stent retriever, thrombus aspiration, others, or combination methods.
Best medical management
Patients enrolled in this group received the best medical management.
Interventions
Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging. Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices
Eligibility Criteria
All acute ischemic strvoke patients with vertebrobasilar artery occlusion.
You may qualify if:
- Patient admitted from Jun. 1st 2019 to Jan. 1st 2029;
- Patients with acute ischemic stroke recently;
- Symptoms persisted at admission, and MRI (including DWI) confirmed acute ischemic vertebrobasilar artery occlusion in the posterior circulation:(single right or left intracranial branch of vertebral artery occlusion ; single basilar occlusion ; both two vertebral arterys and basilar artery);
You may not qualify if:
- Patiens can not meet the MRI examination conditions(with absolute and relative contraindications).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
The Sencond Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, 300211, China
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, 300222, China
Beijing University Binhai Hospital
Tianjin, Tianjin Municipality, 300450, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
October 16, 2023
First Posted
October 23, 2023
Study Start
June 1, 2019
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
October 23, 2023
Record last verified: 2023-10